Insight A Conversation with WIT’s ITC Practice Chair: Examining 2024 Trends in Section 337 Investigations
Insights Home Insights Featured Content Q&As Presenting Expert Testimony: A Q&A with one of the Nation’s Leading Trial Consultants We sat down with Dr. Ellen Brickman, a prominent jury consultant from DOAR, to gain insight on how best to engage with expert witnesses from an insider's perspective. Read what she had to say about leveraging expert witnesses to their fullest potential. Case Study Case Study: Cryptocurrency Expert Needed for Breach of Contract Dispute To aid in their billion-dollar legal battle over a revoked currency purchase option, the plaintiff approached WIT to provide a cryptocurrency expert with deep expertise in options trading. Read the case study to learn how WIT was able to meet the expert need. Q&As A Biotechnology Expert Assesses the Life Sciences Landscape We asked WIT biotechnology expert and accomplished academic, Dr. Brenda Wilson, to evaluate the industry with respect to ongoing trends, impactful innovations, and litigation challenges. Q&As A Conversation with WIT’s ITC Practice Chair: Examining 2024 Trends in Section 337 Investigations We spoke to our ITC Practice Chair, Jeffrey Dorfman, a seasoned New York attorney, to gain insight into ITC investigation trends in 2024. In the News Court Overturns $72 Million Verdict, Landing a Victory for Boeing Against Trades Secrets Claims WIT was proud to have had several experts retained by Hueston Hennigan in support of their representation of Boeing. Insights & News All Industries Automotive Biotechnology Financial Technology Gaming Healthcare Technology Pharmaceutical Wireless Communications All Trends 2023 Banking Crisis 5G / 6G COVID-19 Cryptocurrency Drug and Vaccine Development Election Law and Voting Rights Electric Vehicles FDA-Regulated Drugs and Devices Lab-Grown Foods Mobile Gaming Payment Systems Virtual Reality Wearable Devices All Insight Types Archive Article Blog Case Study Case Study- Life Sciences Case Study- Technology Event In the News Other Content Press Release Q&As Report Video Search August 16, 2024 — Q&As A Biotechnology Expert Assesses the Life Sciences Landscape We asked WIT biotechnology expert and accomplished academic, Dr. Brenda Wilson, to evaluate the industry with respect to ongoing trends, impactful innovations, and litigation challenges. June 18, 2024 — Report A National Study of Community Attitudes Toward Pharmaceutical Companies WIT commissioned the DOAR Research Center to conduct a national study of community attitudes toward pharmaceutical companies and several issues suspected of creating bias. Learn more about their findings. June 12, 2024 — Report Hatch-Waxman Spotlight: Senior Judge Richard Andrews Our latest Hatch-Waxman report provides a comprehensive analysis of Senior Judge Richard Andrews' activity at the United States District Court for the District of Delaware since his appointment in November 2011. Learn more about our findings. March 22, 2024 — Case Study- Life Sciences Case Study: Experienced Urologist Needed for ANDA IP Infringement Dispute The defendant approached WIT to provide an expert who could help bring their drug to market and invalidate the claims of the plaintiff. This case called for an expert who possessed a deep understanding of renal cell carcinoma (kidney cancer). Let's see how WIT was able to meet the ask. March 20, 2024 — Press Release WIT Legal Releases New Report on 2023 Activities and Trends in Hatch-Waxman Litigation The report examines Abbreviated New Drug Application (ANDA) cases and the Orange Book-listed products at issue. October 25, 2023 — Event ACI’s 28th Annual Conference on Drug & Medical Device Litigation WIT Legal will be sponsoring ACI's 28th Annual Conference on Drug & Medical Device Litigation on December 5-6 in NYC. October 2, 2023 — Article Expert Perspective: What is Driving Growth and Litigation in the Biotechnology Space? The biotechnology market is headed towards transformational growth as the landscape shifts, resulting from impending patent cliffs, increased M&A activity, and ongoing innovation. WIT biotech expert Peter Lankau provides insights on what's to come in the industry for the remainder of this year and beyond. July 26, 2023 — Blog Big Pharma’s Balancing Act: Navigating Patent Thickets in the Age of Biosimilars Biosimilar patent cases are complex legal battles that require the support of various experts to bolster the nuanced arguments presented by pharmaceutical companies. May 24, 2023 — In the News Will the FTC’s Amgen Suit Ignite Future Pharmaceutical M&A Conflicts? With M&A activity in the life sciences sector heating up, the latest dispute in the space may affect the future of pharmaceutical acquisitions. How will the FTC's recent case against Amgen ignite future M&A conflicts, and where can experts assist in the litigation process? May 17, 2023 — Article Retaining Experts for Three Top Trends in Life Sciences in 2023 What are three growing trends in life sciences with legal implications, their drivers, and the types of experts that would be advantageous to retain? Learn more. Load More Loading...
Q&As Presenting Expert Testimony: A Q&A with one of the Nation’s Leading Trial Consultants We sat down with Dr. Ellen Brickman, a prominent jury consultant from DOAR, to gain insight on how best to engage with expert witnesses from an insider's perspective. Read what she had to say about leveraging expert witnesses to their fullest potential.
Case Study Case Study: Cryptocurrency Expert Needed for Breach of Contract Dispute To aid in their billion-dollar legal battle over a revoked currency purchase option, the plaintiff approached WIT to provide a cryptocurrency expert with deep expertise in options trading. Read the case study to learn how WIT was able to meet the expert need.
Q&As A Biotechnology Expert Assesses the Life Sciences Landscape We asked WIT biotechnology expert and accomplished academic, Dr. Brenda Wilson, to evaluate the industry with respect to ongoing trends, impactful innovations, and litigation challenges.
Q&As A Conversation with WIT’s ITC Practice Chair: Examining 2024 Trends in Section 337 Investigations We spoke to our ITC Practice Chair, Jeffrey Dorfman, a seasoned New York attorney, to gain insight into ITC investigation trends in 2024.
In the News Court Overturns $72 Million Verdict, Landing a Victory for Boeing Against Trades Secrets Claims WIT was proud to have had several experts retained by Hueston Hennigan in support of their representation of Boeing.
August 16, 2024 — Q&As A Biotechnology Expert Assesses the Life Sciences Landscape We asked WIT biotechnology expert and accomplished academic, Dr. Brenda Wilson, to evaluate the industry with respect to ongoing trends, impactful innovations, and litigation challenges.
June 18, 2024 — Report A National Study of Community Attitudes Toward Pharmaceutical Companies WIT commissioned the DOAR Research Center to conduct a national study of community attitudes toward pharmaceutical companies and several issues suspected of creating bias. Learn more about their findings.
June 12, 2024 — Report Hatch-Waxman Spotlight: Senior Judge Richard Andrews Our latest Hatch-Waxman report provides a comprehensive analysis of Senior Judge Richard Andrews' activity at the United States District Court for the District of Delaware since his appointment in November 2011. Learn more about our findings.
March 22, 2024 — Case Study- Life Sciences Case Study: Experienced Urologist Needed for ANDA IP Infringement Dispute The defendant approached WIT to provide an expert who could help bring their drug to market and invalidate the claims of the plaintiff. This case called for an expert who possessed a deep understanding of renal cell carcinoma (kidney cancer). Let's see how WIT was able to meet the ask.
March 20, 2024 — Press Release WIT Legal Releases New Report on 2023 Activities and Trends in Hatch-Waxman Litigation The report examines Abbreviated New Drug Application (ANDA) cases and the Orange Book-listed products at issue.
October 25, 2023 — Event ACI’s 28th Annual Conference on Drug & Medical Device Litigation WIT Legal will be sponsoring ACI's 28th Annual Conference on Drug & Medical Device Litigation on December 5-6 in NYC.
October 2, 2023 — Article Expert Perspective: What is Driving Growth and Litigation in the Biotechnology Space? The biotechnology market is headed towards transformational growth as the landscape shifts, resulting from impending patent cliffs, increased M&A activity, and ongoing innovation. WIT biotech expert Peter Lankau provides insights on what's to come in the industry for the remainder of this year and beyond.
July 26, 2023 — Blog Big Pharma’s Balancing Act: Navigating Patent Thickets in the Age of Biosimilars Biosimilar patent cases are complex legal battles that require the support of various experts to bolster the nuanced arguments presented by pharmaceutical companies.
May 24, 2023 — In the News Will the FTC’s Amgen Suit Ignite Future Pharmaceutical M&A Conflicts? With M&A activity in the life sciences sector heating up, the latest dispute in the space may affect the future of pharmaceutical acquisitions. How will the FTC's recent case against Amgen ignite future M&A conflicts, and where can experts assist in the litigation process?
May 17, 2023 — Article Retaining Experts for Three Top Trends in Life Sciences in 2023 What are three growing trends in life sciences with legal implications, their drivers, and the types of experts that would be advantageous to retain? Learn more.
